But what would the brand of filler do to cause nodules? Assuming a batch of
PMMA from a certain brand was less than ideal quality in a given instance... how would that necessarily promote
Nodule formation any more than a batch of premium quality
PMMA? I suppose if the assertion was \"granuloma risks due to less than desirable quality
PMMA,\" speculation, it could be warranted. But aesthetic results vary between brands, between concentrations, and between volumes. Seeings how I\'ve read (probably almost) all
PMMA progress reports since late 2010, I just don\'t think I\'ve ever picked up on a strong correlation between brands. Heck, the very best result I got was New Plastic, which was rebranded as \"Linnea Safe.\" I\'ve seen men get stellar 30% results while some regret 30% altogether. Even if we were to graph every result with precision, I\'m willing to wager it\'d still be difficult to conclude any correlation was specifically due to brand...especially given that there are so many other factors involved (e.g. post-op protocol, body\'s own reaction to product, overall health & supplementing(?) ).
I guess what I\'m saying is that I don\'t agree with the claim that one brand was more problematic than the other because of the brand alone. Factor other things too, like the evolution of bioplasty. For example, when New Plastic (a.k.a. Linnea Safe) and early accounts of Metacril involved Dr. C injecting lower volumes than he does today, and that\'s when he was offering 20% as his preferred choice. As time went on, 30% became much more acceptable, as did higher volumes (cc\'s). This could easily influence our perception on \"the brand\" being the problem, when maybe it could be anything but. Just my 2 cents.